Swedish Orphan Biovitrum AB (publ) (BIOVF)

BIOVF Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	997	1,140	904	1,361	1,045	404
Cash & Short-Term Investments	997	1,140	904	1,361	1,045	404
Cash Growth	89.18%	26.11%	-33.58%	30.24%	158.66%	-45.18%
Accounts Receivable	5,135	6,976	6,460	5,582	3,760	4,060
Other Receivables	1,699	405	602	558	345	465
Receivables	6,834	7,381	7,062	6,140	4,105	4,525
Inventory	3,884	4,159	3,874	3,332	3,424	3,053
Prepaid Expenses	-	395	255	254	197	186
Other Current Assets	-	87	65	123	7	-
Total Current Assets	11,715	13,162	12,160	11,210	8,778	8,168
Property, Plant & Equipment	1,577	1,584	1,302	274	493	534
Long-Term Investments	-	36	37	64	145	132
Goodwill	9,639	10,456	9,642	7,007	6,288	5,873
Other Intangible Assets	45,717	48,306	49,586	32,259	31,619	32,372
Long-Term Deferred Tax Assets	1,060	1,293	844	877	767	611
Long-Term Deferred Charges	-	209	352	747	517	546
Other Long-Term Assets	412	398	104	58	54	47
Total Assets	70,120	75,444	74,027	52,496	48,661	48,283
Accounts Payable	1,069	944	1,024	1,252	558	569
Accrued Expenses	-	5,771	5,460	5,296	4,779	4,250
Short-Term Debt	3,909	3,926	3,891	2,067	-	-
Current Portion of Long-Term Debt	-	-	4,922	3,729	1,768	4,015
Current Portion of Leases	103	134	148	134	114	111
Current Income Taxes Payable	-	744	74	23	40	518
Other Current Liabilities	6,880	1,081	3,576	2,356	1,502	980
Total Current Liabilities	11,961	12,600	19,095	14,857	8,761	10,443
Long-Term Debt	9,746	12,407	11,356	2,971	8,777	10,137
Long-Term Leases	263	268	168	200	247	308
Long-Term Deferred Tax Liabilities	6,331	6,702	6,680	3,797	3,605	3,464
Other Long-Term Liabilities	2,782	2,896	2,651	4,059	3,920	3,581
Total Liabilities	31,083	35,149	40,160	25,971	25,458	28,077
Common Stock	195	195	194	170	169	167
Additional Paid-In Capital	17,250	17,186	16,552	10,211	9,945	9,816
Retained Earnings	22,799	21,924	18,055	15,793	13,155	10,477
Comprehensive Income & Other	-1,215	981	-934	351	-66	-254
Total Common Equity	39,029	40,286	33,867	26,525	23,203	20,206
Minority Interest	8	9	-	-	-	-
Shareholders' Equity	39,037	40,295	33,867	26,525	23,203	20,206
Total Liabilities & Equity	70,120	75,444	74,027	52,496	48,661	48,283
Total Debt	14,021	16,735	20,485	9,101	10,906	14,571
Net Cash (Debt)	-13,024	-15,595	-19,581	-7,740	-9,861	-14,167
Net Cash Per Share	-37.61	-45.13	-60.07	-25.93	-33.22	-47.60
Filing Date Shares Outstanding	343.46	343.44	339.76	296.02	295.16	294.9
Total Common Shares Outstanding	343.46	343.44	339.76	296.02	295.16	294.9
Working Capital	-246	562	-6,935	-3,647	17	-2,275
Book Value Per Share	113.64	117.30	99.68	89.61	78.61	68.52
Tangible Book Value	-16,327	-18,476	-25,361	-12,741	-14,704	-18,039
Tangible Book Value Per Share	-47.54	-53.80	-74.64	-43.04	-49.82	-61.17
Machinery	-	696	666	648	673	646
Construction In Progress	-	1,161	1,063	8	23	9

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.